contents
Welcome to
Life Science Leader
@
RFWrightLSL
linkedin.com/in/robertfwright pinterest.com/rfwrightlsl
facebook.com/LifeScienceLeader
W W W. LI FE S CI E N CE LE A D E R .CO M
Columns: Insights:
Reports:
6
8
N O V E M B E R 2 014 V O L . 6 N O. 1 1
LIFE SCIENCE LEADER (ISSN: 21610800) Vol. 6, No.11 is published monthly by Jameson Publishing, Inc. at Knowledge Park, 5340
Fryling Road, Suite 300, Erie, PA 16510-4672. Phone (814) 897-9000, Fax (814) 899-5580. Periodical postage paid at Erie, PA 16510 and
additional mailing offices. Copyright 2014 by Peterson Partnership. All rights reserved. Printed in the USA.
SUBSCRIPTION RATES for qualified readers in the U.S. $0. For nonqualified readers in the U.S. and all other countries $97 for one
year. If your mailing address is outside the U.S. or Canada, you can receive the magazine digitally if you provide a valid email address.
POSTMASTER: Send address corrections (Form 3579) to Life Science Leader, Knowledge Park, 5340 Fryling Road, Suite 300, Erie, PA
16510-4672. PUBLICATIONS AGREEMENT No. 40722524 c/o AIM, 7289 Torbram Road, Mississauga, ON L4T 1G8
36
Combination Cancer Immunotherapy —
A Virtual Roundtable
A Series on the Challenges and Opportunities
of Using New Agents to Rally the Immune
System Against Cancer
30
How to Build Real Patient-Centered
Pharmaceutical Companies
Chief Editor Rob Wright's exclusive interview
with the executive team at PatientsLikeMe
LIFESCIENCELEADER.COM NOVEMBER 2014
4
Features:
Editor's Note
Editorial Advisory Board / Ask The Board
OUTSOURCING INSIGHTS | By Kate Hammeke
Logistics Providers Strive to Fulfill Biopharma Needs – Specialty
Companies Offer Advantages, but Get a Bad Rap on Price
BIO INNOVATION NOTES | By Eric Langer
The Biosimilars Opportunity:
4 Years Of Waiting
We had to reintroduce personal
accountability and individual leadership.
Dr. Patrick Vallance, President of Pharmaceuticals R&D; at GlaxoSmithKline
24
Cover Story:
20
16
14
Companies
To Watch
GLAXOSMITHKLINE
10
Capitol
Perspectives
BIOPHARMA
By Cliff Mintz
Cannabis-Based
Pharmaceuticals:
The Next Frontier?
46
"The market is large
enough to support both the
nutraceutical/herbal remedies
and pharmaceutical sides
of the business"
Trevor Castor,
CEO of Aphios Corp.
Online Exclusive
Chief Editor Rob Wright recently was
invited to attend a private dinner
hosted by the National Journal
that included top executives from
companies such as AstraZeneca,
Lilly, and BIO. The focus of the dinner
discussion was personalized medicine.
Read Rob's insights from the dinner at his blog
at
www.lifescienceleader.com/blog/robs-blog.
50
LEADERSHIP LESSONS
By Tony Bendell
Am I Learning
from the
Failure
of Others?
Why it's important
for you to make your
company "anti-fragile."